• 1
    Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2008. on November 2008 SEER data submission, posted to the SEER website, 2009. Accessed on October 13, 2010.
  • 2
    Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
  • 3
    Shwartz M. Estimates of lead time and length bias in a breast cancer screening program. Cancer. 1980; 46: 844-851.
  • 4
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004; 101: 3-27.
  • 5
    Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev. 2009; 18: 121-131.
  • 6
    Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008; 113: 582-591.
  • 7
    Yu XQ. Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race [serial online]. BMC Cancer. 2009; 9: 364.
  • 8
    Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol. 1992; 135: 609-618.
  • 9
    Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986; 76: 1400-1403.
  • 10
    Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Breast cancer survival in Ontario and California, 1998-2006: socioeconomic inequity remains much greater in the United States. Ann Epidemiol. 2009; 19: 121-124.
  • 11
    Greenwald HP, Polissar NL, Dayal HH. Race, socioeconomic status and survival in 3 female cancers. Ethn Health. 1996; 1: 65-75.
  • 12
    Bigby J, Holmes MD. Disparities across the breast cancer continuum. Cancer Causes Control. 2005; 16: 35-44.
  • 13
    Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the US: what have we learned from clinical studies. Cancer. 2002; 95: 1988-1999.
  • 14
    Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic status in health research: 1 size does not fit all. JAMA. 2005; 294: 2879-2888.
  • 15
    Baquet CR, Commiskey P. Socioeconomic factors and breast carcinoma in multicultural women. Cancer. 2000; 88( 5 suppl): 1256-1264.
  • 16
    Vona-Davis L, Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt). 2009; 18: 883-893.
  • 17
    Robert SA. Socioeconomic position and health: the independent contribution of community socioeconomic context. Annu Rev Sociol. 1999; 25: 489-516.
  • 18
    Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16: 236-243.
  • 19
    Nelson SE, Gould MN, Hampton JM, Trentham-Dietz A. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res. 2005; 7: R357-R364.
  • 20
    US Census Bureau. 2000 Census of Population and Housing, Summary File 3: Washington, DC: US Census Bureau; 2002. Accessed on October 13, 2010.
  • 21
    McElroy JA, Remington PL, Trentham-Dietz A, Robert SA, Newcomb PA. Geocoding addresses from a large population-based study: lessons learned. Epidemiology. 2003; 14: 399-407.
  • 22
    Robert SA, Strombom I, Trentham-Dietz A, et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology. 2004; 15: 442-450.
  • 23
    Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology, 3rd Edition., Geneva, Switzerland: World Health Organization; 2000.
  • 24
    Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol. 1993; 137: 235-241.
  • 25
    World Health Organization. International Classification of Diseases, 9th Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
  • 26
    World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1994.
  • 27
    United States Department of Health and Human Services, Office of the Secretary. Annual update of the HHS Poverty Guidelines. Fed Reg. 2000; 65: 7555-7557.
  • 28
    Schafer JL. Analysis of incomplete multivariate data. New York: Chapman and Hall; 1997.
  • 29
    Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
  • 30
    Lin DY, Wei LJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989; 84: 1074-1078.
  • 31
    Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer; 1997.
  • 32
    Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998; 148: 475-486.
  • 33
    Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993; 329: 326-331.
  • 34
    Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001; 91: 178-188.
  • 35
    Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002; 94: 490-496.
  • 36
    Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL. Effects of race and socioeconomic status on survival of 1332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997; 4: 111-118.
  • 37
    National Center for Health Statistics. Health, United States, 2008 with Chartbook, 2008. Hyattsville, Md: National Center for Health Statistics; 2008.
  • 38
    Katz SJ, Zemencuk JK, Hofer TP. Breast cancer screening in the United States and Canada, 1994: socioeconomic gradients persist. Am J Public Health. 2000; 90: 799-803.
  • 39
    Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003; 97: 1528-1540.
  • 40
    Dailey AB, Kasl SV, Holford TR, Calvocoressi L, Jones BA. Neighborhood-level socioeconomic predictors of nonadherence to mammography screening guidelines. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2293-2303.
  • 41
    Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology, and End Results National Longitudinal Mortality Study. Cancer Causes Control. 2009; 20: 417-435.
  • 42
    Hahn KM, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007; 166: 1035-1044.
  • 43
    Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998; 279: 1801-1807.
  • 44
    Pinsky PF, Miller A, Kramer BS, et al. Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol. 2007; 165: 874-881.
  • 45
    Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JO. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Commun Health. 1992; 46: 362-364.
  • 46
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003; 289: 76-79.
  • 47
    Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008; 107: 309-330.
  • 48
    Newcomb PA, Egan KM, Trentham-Dietz A, et al. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 864-871.
  • 49
    Schairer C, Gail M, Byrne C, et al. Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst. 1999; 91: 264-270.
  • 50
    Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365: 1687-1717.
  • 51
    Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109: 1721-1728.
  • 52
    Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol. 1995; 142: 1255-1264.